Home LiteratureArticle Details
PMID: 15067316 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication.

The Journal of clinical investigation ·Vol. 113 ·No. 6 ·2004-03-00 ·Pages 836-45

Garber DA, Silvestri G, Barry AP, Fedanov A, Kozyr N, McClure H, Montefiori DC, Larsen CP, Altman JD, Staprans SI, Feinberg MB

Abstract

In vivo blockade of CD28 and CD40 T cell costimulation pathways during acute simian immunodeficiency virus (SIV) infection of rhesus macaques was performed to assess the relative contributions of CD4+ T cells, CD8+ T cells, and Ab responses in modulating SIV replication and disease progression. Transient administration of CTLA4-Ig and anti-CD40L mAb to SIV-infected rhesus macaques resulted in dramatic inhibition of the generation of both SIV-specific cellular and humoral immune responses. Acute levels of proliferating CD8+ T cells were associated with early control of SIV viremia but did not predict ensuing set point viremia or survival. The level of in vivo CD4+ T cell proliferation during acute SIV infection correlated with concomitant peak levels of SIV plasma viremia, whereas measures of in vivo CD4+ T cell proliferation that extended into chronic infection correlated with lower SIV viral load and increased survival. These results suggest that proliferating CD4+ T cells function both as sources of virus production and as antiviral effectors and that increased levels of CD4+ T cell proliferation during SIV infections reflect antigen-driven antiviral responses rather than a compensatory homeostatic response. These results highlight the interrelated actions of CD4+ and CD8+ T cell responses in vivo that modulate SIV replication and pathogenesis.

MeSH Terms
Animals CD4-Positive T-Lymphocytes/metabolism CD8-Positive T-Lymphocytes/metabolism Enzyme-Linked Immunosorbent Assay Interferon-gamma/metabolism Macaca mulatta/virology Simian Acquired Immunodeficiency Syndrome/metabolism Simian Immunodeficiency Virus/metabolism Viral Load Virus Replication/physiology
Chemicals
Interferon-gamma
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Garber David A
Emory Vaccine Center, Atlanta, Georgia 30329, USA.
Silvestri Guido
Barry Ashley P
Fedanov Andrew
Kozyr Natalia
McClure Harold
Montefiori David C
Larsen Christian P
Altman John D
Staprans Silvija I
Feinberg Mark B
References (74)
74 references, click to expand
  1. A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing.
    Tissue Antigens. 1997 Dec;50(6):657-61 PMID: 9458122
  2. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.
    Nat Med. 1999 Nov;5(11):1270-6 PMID: 10545993
  3. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.
    Science. 1999 Nov 12;286(5443):1353-7 PMID: 10558989
  4. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.
    J Exp Med. 2000 Jul 3;192(1):63-75 PMID: 10880527
  5. Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection.
    J Virol. 2000 Sep;74(18):8413-24 PMID: 10954541
  6. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand.
    Nature. 1995 Dec 7;378(6557):617-20 PMID: 8524395
  7. CD40 ligand-transduced co-stimulation of T cells in the development of helper function.
    Nature. 1995 Dec 7;378(6557):620-3 PMID: 8524396
  8. Reduction of HIV concentration during acute infection: independence from a specific immune response.
    Science. 1996 Jan 26;271(5248):497-9 PMID: 8560262
  9. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.
    Science. 1996 Mar 15;271(5255):1582-6 PMID: 8599114
  10. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.
    J Virol. 1996 Jun;70(6):3741-52 PMID: 8648709
  11. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
    Science. 1996 May 24;272(5265):1167-70 PMID: 8638160
  12. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
    Nature. 1996 May 30;381(6581):434-8 PMID: 8632801
  13. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.
    Science. 1996 Sep 27;273(5283):1862-4 PMID: 8791591
  14. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.
    Science. 1996 Sep 27;273(5283):1864-7 PMID: 8791592
  15. Functions of CD40 and its ligand, gp39 (CD40L).
    Crit Rev Immunol. 1996;16(1):59-108 PMID: 8809473
  16. Phenotypic analysis of antigen-specific T lymphocytes.
    Science. 1996 Oct 4;274(5284):94-6 PMID: 8810254
  17. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems.
    AIDS Res Hum Retroviruses. 2000 Sep 1;16(13):1247-57 PMID: 10957722
  18. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
    Nature. 2000 Sep 21;407(6802):386-90 PMID: 11014195
  19. Functional impairment of simian immunodeficiency virus-specific CD8+ T cells during the chronic phase of infection.
    J Virol. 2001 Mar;75(5):2458-61 PMID: 11160749
  20. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
    Nature. 2001 Mar 1;410(6824):106-11 PMID: 11242051
  21. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.
    Nat Immunol. 2000 Oct;1(4):285-9 PMID: 11017098
  22. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
    Science. 2001 Apr 6;292(5514):69-74 PMID: 11393868
  23. The dynamics of CD4+ T-cell depletion in HIV disease.
    Nature. 2001 Apr 19;410(6831):974-9 PMID: 11309627
  24. Conventional immunosuppression and co-stimulation blockade.
    Philos Trans R Soc Lond B Biol Sci. 2001 May 29;356(1409):703-5 PMID: 11375073
  25. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.
    J Virol. 2001 Aug;75(15):6953-61 PMID: 11435575
  26. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.
    J Exp Med. 2001 Nov 5;194(9):1277-87 PMID: 11696593
  27. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.
    J Virol. 2002 Jan;76(2):875-84 PMID: 11752176
  28. Antigen presentation and T cell stimulation by dendritic cells.
    Annu Rev Immunol. 2002;20:621-67 PMID: 11861614
  29. Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS.
    Blood. 2002 Apr 1;99(7):2505-11 PMID: 11895786
  30. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?
    Nat Med. 2002 Apr;8(4):319-23 PMID: 11927927
  31. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
    Nat Med. 2002 May;8(5):493-9 PMID: 11984594
  32. HIV preferentially infects HIV-specific CD4+ T cells.
    Nature. 2002 May 2;417(6884):95-8 PMID: 11986671
  33. The HIV-1 vaccine race.
    Cell. 2002 Jul 26;110(2):135-8 PMID: 12150921
  34. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.
    J Immunol. 2002 Sep 15;169(6):3400-6 PMID: 12218162
  35. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.
    Science. 2002 Sep 20;297(5589):2060-3 PMID: 12242444
  36. Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys.
    Blood. 2003 Feb 15;101(4):1213-9 PMID: 12393472
  37. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.
    Immunity. 2003 Mar;18(3):441-52 PMID: 12648460
  38. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.
    J Virol. 2003 Apr;77(8):4911-27 PMID: 12663797
  39. Rapid evolution of the neutralizing antibody response to HIV type 1 infection.
    Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4144-9 PMID: 12644702
  40. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
    Immunity. 1998 Feb;8(2):177-87 PMID: 9491999
  41. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.
    Nature. 1998 Jun 4;393(6684):474-8 PMID: 9624003
  42. Help for cytotoxic-T-cell responses is mediated by CD40 signalling.
    Nature. 1998 Jun 4;393(6684):478-80 PMID: 9624004
  43. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
    Nature. 1998 Jun 4;393(6684):480-3 PMID: 9624005
  44. T cell responses and viral escape.
    Cell. 1998 May 29;93(5):673-6 PMID: 9630211
  45. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.
    J Immunol. 1998 Jun 15;160(12):6062-71 PMID: 9637523
  46. Development and homeostasis of T cell memory in rhesus macaque.
    J Immunol. 2002 Jan 1;168(1):29-43 PMID: 11751943
  47. CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection.
    J Virol. 1998 Sep;72(9):7440-9 PMID: 9696840
  48. Viral immune evasion due to persistence of activated T cells without effector function.
    J Exp Med. 1998 Dec 21;188(12):2205-13 PMID: 9858507
  49. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Science. 1999 Feb 5;283(5403):857-60 PMID: 9933172
  50. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.
    J Exp Med. 1999 Mar 15;189(6):991-8 PMID: 10075982
  51. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys.
    J Immunol. 1999 May 1;162(9):5127-33 PMID: 10227983
  52. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.
    J Virol. 1999 Jun;73(6):4829-39 PMID: 10233944
  53. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.
    Annu Rev Immunol. 1999;17:625-56 PMID: 10358770
  54. CD28/CTLA-4 and CD80/CD86 families: signaling and function.
    Immunol Res. 1999;19(1):1-24 PMID: 10374692
  55. Requirement for CD4 T cell help in generating functional CD8 T cell memory.
    Science. 2003 Apr 11;300(5617):337-9 PMID: 12690201
  56. Defective CD8 T cell memory following acute infection without CD4 T cell help.
    Science. 2003 Apr 11;300(5617):339-42 PMID: 12690202
  57. Turnover of lymphocytes and conceptual paradigms in HIV infection.
    J Clin Invest. 2003 Sep;112(6):821-4 PMID: 12975464
  58. Roles of target cells and virus-specific cellular immunity in primary simian immunodeficiency virus infection.
    J Virol. 2004 May;78(9):4866-75 PMID: 15078967
  59. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.
    J Immunol. 1984 Oct;133(4):1710-5 PMID: 6206131
  60. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys.
    J Immunol. 1991 Jul 1;147(1):320-9 PMID: 1711081
  61. CTLA-4 is a second receptor for the B cell activation antigen B7.
    J Exp Med. 1991 Sep 1;174(3):561-9 PMID: 1714933
  62. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.
    Science. 1992 Aug 7;257(5071):792-5 PMID: 1496399
  63. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.
    J Virol. 1994 Apr;68(4):2362-70 PMID: 8139022
  64. Titration and characterization of two rhesus-derived SIVmac challenge stocks.
    AIDS Res Hum Retroviruses. 1994 Feb;10(2):213-20 PMID: 8198874
  65. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  66. Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. National Institutes of Health AIDS Vaccine Clinical Trials Networks.
    J Infect Dis. 1994 Aug;170(2):429-32 PMID: 8035031
  67. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  68. Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA4Ig treatment.
    J Immunol. 1995 Jun 1;154(11):5885-95 PMID: 7751633
  69. Formation of simian immunodeficiency virus long terminal repeat circles in resting T cells requires both T cell receptor- and IL-2-dependent activation.
    J Exp Med. 1995 Aug 1;182(2):617-21 PMID: 7629519
  70. Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys.
    J Immunol. 1996 Dec 15;157(12):5528-35 PMID: 8955203
  71. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.
    J Virol. 1997 Jan;71(1):284-90 PMID: 8985348
  72. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.
    J Virol. 1997 Apr;71(4):2799-809 PMID: 9060635
  73. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
    Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8789-94 PMID: 9238056
  74. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.
    J Virol. 1998 Jan;72(1):164-9 PMID: 9420212
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2004-03-00
Pages
836-45
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC362114
Subset
IM
Grants
NIAID NIH HHS · P30 AI050409 · United States
NIAID NIH HHS · T32 AI007442 · United States
NIAID NIH HHS · R01 AI049155 · United States
NIAID NIH HHS · T32-AI07470 · United States
NCRR NIH HHS · P51 RR00165-42 · United States
NIAID NIH HHS · T32-AI07442 · United States
NIAID NIH HHS · P30 AI50409-04A1 · United States
NIAID NIH HHS · R01-AI49155-02 · United States
NCRR NIH HHS · P51 RR000165 · United States
NIAID NIH HHS · T32 AI007470 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com